tiprankstipranks
Trending News
More News >
Molecular Partners AG (CH:MOLN)
:MOLN
Switzerland Market
Advertisement

Molecular Partners AG (MOLN) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

MOLN Financial Forecast

MOLN Earnings Forecast

Next quarter’s earnings estimate for MOLN is -CHF0.28 with a range of -CHF0.28 to -CHF0.28. The previous quarter’s EPS was -CHF0.55. MOLN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MOLN has Performed in-line its overall industry.
Next quarter’s earnings estimate for MOLN is -CHF0.28 with a range of -CHF0.28 to -CHF0.28. The previous quarter’s EPS was -CHF0.55. MOLN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MOLN has Performed in-line its overall industry.

MOLN Sales Forecast

Next quarter’s sales forecast for MOLN is CHF0.00 with a range of CHF0.00 to CHF0.00. The previous quarter’s sales results were CHF0.00. MOLN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MOLN has Performed in-line its overall industry.
Next quarter’s sales forecast for MOLN is CHF0.00 with a range of CHF0.00 to CHF0.00. The previous quarter’s sales results were CHF0.00. MOLN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MOLN has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:MOLN
J.P. Morgan
J.P. Morgan
CHF4CHF3.5
Hold
5.42%
Upside
Reiterated
09/03/25
Molecular Partners AG (MLLCF) Gets a Hold from J.P. Morgan
TD Cowen
CHF15
Buy
351.81%
Upside
Reiterated
08/26/25
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:MOLN
J.P. Morgan
J.P. Morgan
CHF4CHF3.5
Hold
5.42%
Upside
Reiterated
09/03/25
Molecular Partners AG (MLLCF) Gets a Hold from J.P. Morgan
TD Cowen
CHF15
Buy
351.81%
Upside
Reiterated
08/26/25
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molecular Partners AG

1 Month
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-6.08%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -6.08% per trade.
3 Months
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
-0.40%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -0.40% per trade.
1 Year
Success Rate
1/4 ratings generated profit
25%
Average Return
-9.63%
reiterated a buy rating 3 months ago
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -9.63% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-15.85%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -15.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MOLN Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
1
1
1
1
0
Buy
0
0
0
0
0
Hold
10
9
8
7
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
10
9
8
9
In the current month, MOLN has received 0 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. MOLN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MOLN Stock Forecast FAQ

What is CH:MOLN’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:MOLN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:MOLN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Molecular Partners AG a Buy, Sell or Hold?
      Molecular Partners AG has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Molecular Partners AG’s share price target?
        Currently, no data Available
        What do analysts say about Molecular Partners AG?
        Molecular Partners AG’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Molecular Partners AG?
          To buy shares of CH:MOLN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis